Abbott, GenLab Developing Molecular Assay for Orthopedic Infections | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today announced a deal with Genetics Laboratory to develop and commercialize an assay for the detection of infections in bones and joints.

The assay will be developed for use on Abbott's Plex-ID automated platform for the identification of microbes. The platform is intended for non-diagnostic use only in the US, but assays are being developed for future clinical diagnostic purposes, Abbott said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.